Literature DB >> 947848

The long-term outcome of hepatitis B.

G Norkrans, S Hermodsson, P Lundin, S Iwarson.   

Abstract

Among 466 hospitalized patients with serologically verified acute hepatitis B, 440 individuals (94.4%) could be followed up until normalization of liver function had occured, or for at least one year. In 90.2% of the patients followed-up liver function including galactose tolerance) returned to normal within four months after onset of illness. Chronic persistent hepatitis B surface antigen (HB Ag) for at least one year in 14 patients (50%). Liver biopsy was performed in consistent with CPH in all cases. Histological signs of chronic aggressive hepatitis developed in 15 patients (3.4%) and persistence of HB Ag was observed in 11 of these patients (73%). No histological follow-up was performed in patients with normal liver function within four months after onset of illness. Cprticosteroid treatment in 56 patients with prolonged symptoms did not seem to predispose to persistence of HbsaG in the serum.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 947848     DOI: 10.1007/bf01638719

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme.

Authors:  J O Nielsen; O Dietrichson; E Juhl
Journal:  Lancet       Date:  1974-10-19       Impact factor: 79.321

2.  Natural history of hepatitis-associated antigen-positive chronic liver disease.

Authors:  F J Dudley; P J Scheuer; S Sherlock
Journal:  Lancet       Date:  1972-12-30       Impact factor: 79.321

3.  Comparison between the immunoelectroosmophoresis and the Ouchterlony precipitation technique in detecting Australia antigen in cases of hepatitis.

Authors:  B G Hansson; C O Kindmark; T Johnsson
Journal:  Vox Sang       Date:  1970 Sep-Oct       Impact factor: 2.144

4.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

5.  Prognosis of chronic persistent hepatitis.

Authors:  M D Becker; A Baptista; P J Scheuer; S Sherlock
Journal:  Lancet       Date:  1970-01-10       Impact factor: 79.321

6.  Multiple attacks of hepatitis in drug addicts: biochemical, immunochemical, and morphologic characteristics.

Authors:  S Iwarson; P Lundin; J Holmgren; S Hermodsson
Journal:  J Infect Dis       Date:  1973-05       Impact factor: 5.226

7.  Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis.

Authors:  J O Nielsen; O Dietrichson; P Elling; P Christoffersen
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

8.  A fortuitously controlled study of steroid therapy in acute viral hepatitis. II. Follow-up examination of 202 patients.

Authors:  R Stutz; A L Blum; U P Haemmerli; P Schmid; M Schmid
Journal:  Am J Med       Date:  1969-07       Impact factor: 4.965

9.  Hepatitis-associated antigen (HAA) in acute viral hepatitis. Serological and clinical studies.

Authors:  S Iwarson; S Hermodsson
Journal:  Scand J Infect Dis       Date:  1971

10.  Liver morphology in acute viral hepatitis related to the hepatitis B antigen.

Authors:  S Iwarson; P Lundin; S Hermodsson
Journal:  J Clin Pathol       Date:  1972-10       Impact factor: 3.411

  10 in total
  1 in total

1.  Altruism in surgery of AIDS patients.

Authors:  Lawrence A Pottenger; Homer U Ashby; Carolyn R Thompson
Journal:  J Relig Health       Date:  1992
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.